Discovery and Optimization of a Series of 3-(3-Phenyl-3Himidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: Orally Bioavailable, Selective, and Potent ATP-Independent Akt Inhibitors
Journal Article
·
· Journal of Medicinal Chemistry
N/A
- Research Organization:
- BROOKHAVEN NATIONAL LABORATORY (BNL)
- Sponsoring Organization:
- USDOE SC OFFICE OF SCIENCE (SC)
- DOE Contract Number:
- AC02-98CH10886
- OSTI ID:
- 1069560
- Report Number(s):
- BNL--100132-2013-JA
- Journal Information:
- Journal of Medicinal Chemistry, Journal Name: Journal of Medicinal Chemistry Journal Issue: 11 Vol. 55; ISSN 0022-2623
- Country of Publication:
- United States
- Language:
- English
Similar Records
Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3 H -imidazo[4,5- b ]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor
Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT
Discovery of a Novel Series of Potent and Orally Bioavailable Phosphoinositide 3-Kinase [gamma] Inhibitors
Journal Article
·
Wed Jun 15 00:00:00 EDT 2016
· Journal of Medicinal Chemistry
·
OSTI ID:1354334
Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT
Journal Article
·
Fri Jun 01 00:00:00 EDT 2018
· Bioorganic and Medicinal Chemistry Letters
·
OSTI ID:1474162
Discovery of a Novel Series of Potent and Orally Bioavailable Phosphoinositide 3-Kinase [gamma] Inhibitors
Journal Article
·
Wed Sep 18 00:00:00 EDT 2013
· J. Med. Chem.
·
OSTI ID:1093490